Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone or Sildenafil for Fatigue in MTBI
NCT02114775Phase 1Completed
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Dec 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of somatropin and ASP-001 in traumatic brain injury (TBI), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Performance fatigue as measured by using hand grip dynamometry at 12 months. Started Dec 2014; status: completed.
02
Drugs
somatropinASP-001
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02114775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02114775.